The present invention provides the S enantiomer of a compound of formula I
wherein R
1
represents chloro, trifluoromethyl or trifluoromethoxy, R
2
represents H or fluoro and R
3
represents a C
2-4
alkyl group as well as pharmaceutically acceptable salts, solvates and prodrugs thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
本发明提供了公式I的化合物的S对映体,其中R1代表
氯、三
氟甲基或三
氟甲氧基,R2代表H或
氟,R3代表C2-4烷基,以及其药学上可接受的盐、溶剂化合物和前药。本发明还提供了制备这些化合物的方法,它们在治疗包括脂质紊乱(失调)的临床病症中的用途,无论是否与
胰岛素抵抗相关,以及它们的治疗用途的方法和包含它们的制药组合物。